IL-18 receptor antagonist and pharmaceutical composition containing the antagonist
OwnerAtsuo Sekiyamainventor
Life of this patent
Estimating the term…
Abstract
Provided is an IL-18 receptor antibody usable for immunohistochemistry, which functions as an IL-18 receptor antagonist. Also provided is a pharmaceutical composition and method for preventing and/or treating an IL-18-dependent disorder, particularly skin thickening caused by ultraviolet, using the antibody. An antibody against the IL-18 receptor α subunit, which is characterized by binding specifically to a polypeptide consisting of the amino acid sequence shown by SEQ ID NO:1, or an antibody against the IL-18 receptor β subunit, which is characterized by binding specifically to a polypeptide consisting of the amino acid sequence shown by SEQ ID NO:2, is prepared.
Claims1
A method of inhibiting ultraviolet-dependent epidermal hardening or thickening in skin comprising applying a pharmaceutical comprising an antibody that specifically binds to a polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:
- 9 to the skin after exposure to ultraviolet irradiation, wherein ultraviolet-dependent epidermal hardening or thickening is inhibited.
Dependencies are inferred from the claim text.